238 related articles for article (PubMed ID: 30148864)
1. Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography.
Zanchin C; Yamaji K; Rogge C; Lesche D; Zanchin T; Ueki Y; Windecker S; Mohacsi P; Räber L; Sigurdardottir V
PLoS One; 2018; 13(8):e0202950. PubMed ID: 30148864
[TBL] [Abstract][Full Text] [Related]
2. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
3. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
Asleh R; Briasoulis A; Pereira NL; Boilson BA; Edwards BS; Adigun R; Maltais S; Daly RC; Lerman A; Kushwaha SS
ESC Heart Fail; 2018 Dec; 5(6):1118-1129. PubMed ID: 30019530
[TBL] [Abstract][Full Text] [Related]
4. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
[TBL] [Abstract][Full Text] [Related]
5. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
[TBL] [Abstract][Full Text] [Related]
7. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
[TBL] [Abstract][Full Text] [Related]
8. Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients.
Nagumo S; Gallinoro E; Candreva A; Mizukami T; Monizzi G; Kodeboina M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Goethals M; Buytaert D; De Bruyne B; Sonck J; Collet C; Vanderheyden M
J Interv Cardiol; 2020; 2020():9835151. PubMed ID: 32733172
[TBL] [Abstract][Full Text] [Related]
9. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
[TBL] [Abstract][Full Text] [Related]
10. Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.
Peled Y; Lavee J; Raichlin E; Katz M; Arad M; Kassif Y; Peled A; Asher E; Elian D; Har-Zahav Y; Shlomo N; Freimark D; Goldenberg I; Klempfner R
Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28990263
[TBL] [Abstract][Full Text] [Related]
11. Intravascular ultrasound for cardiac allograft vasculopathy detection.
Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
[TBL] [Abstract][Full Text] [Related]
12. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.
Taniwaki M; Windecker S; Zaugg S; Stefanini GG; Baumgartner S; Zanchin T; Wenaweser P; Meier B; Jüni P; Räber L
Eur Heart J; 2015 Aug; 36(32):2167-76. PubMed ID: 26040806
[TBL] [Abstract][Full Text] [Related]
13. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Lee MS; Kobashigawa J; Tobis J
JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
[TBL] [Abstract][Full Text] [Related]
14. Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era.
Amancherla K; Feurer ID; Rega SA; Cluckey A; Salih M; Davis J; Pedrotty D; Ooi H; Rali AS; Siddiqi HK; Menachem J; Brinkley DM; Punnoose L; Sacks SB; Zalawadiya SK; Wigger M; Balsara K; Trahanas J; McMaster WG; Hoffman J; Pasrija C; Lindenfeld J; Shah AS; Schlendorf KH
J Card Fail; 2024 May; 30(5):694-700. PubMed ID: 37907147
[TBL] [Abstract][Full Text] [Related]
15. Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study.
Goekler J; Zuckermann A; Kaider A; Angleitner P; Osorio-Jaramillo E; Moayedifar R; Uyanik-Uenal K; Kainz FM; Masetti M; Laufer G; Aliabadi-Zuckermann AZ
Transpl Int; 2018 Aug; 31(8):909-916. PubMed ID: 29577455
[TBL] [Abstract][Full Text] [Related]
16. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
[TBL] [Abstract][Full Text] [Related]
17. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
[TBL] [Abstract][Full Text] [Related]
18. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
[TBL] [Abstract][Full Text] [Related]
19. Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients.
Kindel SJ; Law YM; Chin C; Burch M; Kirklin JK; Naftel DC; Pruitt E; Carboni MP; Arens A; Atz AM; Dreyer WJ; Mahle WT; Pahl E
J Am Coll Cardiol; 2015 Aug; 66(5):547-57. PubMed ID: 26227194
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
